Eclipse Metals Limited (ASX:EPM) has reached a landmark decision with traditional landowners, allowing negotiations with the Northern Land Council (NLC) regarding access to exploration license applications, ELA 31065 and ELA 31770, for uranium-gold-palladium exploration and mining. The new Liverpool Uranium Project tenements situated in the world-class Alligator Rivers Uranium Field adjoin the Company’s Devil’s Elbow Project.
Upon reaching an agreement on the final terms and conditions, the exploration agreement will be ratified with the traditional owners during a final on-country meeting.
Eclipse also updated on a reconnaissance program on the Devil’s Elbow U-Au-Pd prospect and the surrounding radiometric anomalies within EL27584.
EPM stock was trading at AU$0.007 on 30 July 2020 (AEST 12:51 PM).
There is no one left untouched by the charm of the multibillion-dollar global boom in cannabis. Its glorious journey from a criminalized drug to being used in over 20 countries for treating medical conditions.
No wonder the cannabis stocks are on the edge of a green rush. Don’t miss out on the happenings in the cannabis sector and take advantage of the growth phase of this sector by subscribing to our report on Marijuana stocks in Australia.
Find out the drivers for the rise in cannabis stock rates Even though the cannabis sector is in its growing phase, Australian cannabis stocks have already started to rise actively due to a hastily increasing patient base, and a legislative landscape that is gradually beginning to liberalise.
Outreach and future of cannabis stocks As countries liberalise regulation for medical and recreational use of cannabis, it is predicted that the industry would grow sharply in upcoming years The global cannabis market stands currently at around $8 billion and it is expected that the hemp derived CBD market to hit approximately $22 billion by 2022.
Key Players in the sector Althea Group Holdings Limited (ASX: AGH) and Cann Group Limited (ASX: CAN) are amongst the top players. Other Australia cannabis market players are- MGC Pharmaceuticals Ltd (ASX: MXC), Elixinol Global Limited (ASX: EXL), THC Global Group Limited (ASX: THC), AusCann Group Holdings Limited (ASX: AC8)